Read by QxMD icon Read


V Besgen, W Sekundo
The retropupillary implantation of an iris claw intraocular lens (IOL) is an uncomplicated and fast technique for rehabilitation of aphakic eyes without any capsular structures and is presented in a video in the online version of this article. A complete anterior pars plana vitrectomy as shown in our case or an extensive preceding anterior vitrectomy as well as an intact iris are prerequisites. Special instruments for the implantation and fixation of the IOL are available to optimize the operative procedure...
November 2017: Der Ophthalmologe: Zeitschrift der Deutschen Ophthalmologischen Gesellschaft
Marta G Guerra, Andreia M M Silva, Sara H M Marques, Sofia H Melo, João A Póvoa, Conceição Lobo, Joaquim Neto Murta
PURPOSE: To compare endothelial cell (EC) variation after anterior chamber phakic intraocular lens (AC-pIOL) implantation in highly myopic patients with a preoperative anterior chamber depth (ACD) between 2.8 and 3.0 versus ≥3.0 mm. METHODS: A total of 280 eyes submitted to primary AC-pIOL implantation were analyzed. Pre- and postoperative values for uncorrected distance visual acuity, corrected distance visual acuity, spherical equivalent, ACD (endothelial surface), and EC count were collected...
2017: Ophthalmic Research
Sameh Mosaad Fouda, Mahmoud A Al Aswad, Basem M Ibrahim, Ashraf Bori, Hala K Mattout
PURPOSE: This study aimed to evaluate the safety and efficacy of retropupillary fixation of an iris-claw intraocular lens (IOL; Verisyse polymethyl methacrylate IOL, Abbott Medical Optics [AMO], Netherlands) for the surgical correction of aphakia in microspherophakic eyes without sufficient capsular support. DESIGN: This was a prospective, interventional, noncomparative case series. METHODS: This interventional case series comprised 17 eyes of 9 microspherophakic patients...
December 2016: Indian Journal of Ophthalmology
Tamer Tandogan, Mike P Holzer, Chul Young Choi, Gerd U Auffarth, Georg Gerten, Ramin Khoramnia
PURPOSE: To conduct a material analysis of spontaneously subluxated iris-fixated phakic intraocular lenses (IOLs) using light and scanning electron microscopy. METHODS: Six explanted Artisan/Verisyse and Artiflex/Veriflex IOLs (Ophtec, Groningen, Netherlands/AMO, Santa Ana, CA) were analyzed in a laboratory using light and scanning electron microscopy. Four of the IOLs had been explanted after spontaneous subluxation leading to a decrease in visual acuity, whereas the remaining two IOLs did not demonstrate signs of disenclavation but had been explanted in the course of planned cataract surgery and thus served as the control in this study...
August 1, 2016: Journal of Refractive Surgery
Maja Bohac, Marija Anticic, Natasa Draca, Bojan Kozomara, Iva Dekaris, Nikica Gabric, Sudi Patel
PURPOSE: To compare refractive stability, endothelial cell count (ECC), incidence of complications, and patients' satisfaction between a rigid Verisyse (group I, n = 198) and foldable Veriflex (group II, n = 212) phakic intraocular lenses (pIOL) over 36 months postop. MATERIALS AND METHODS: This was a retrospective study. Patients' satisfaction and incidence of photic phenomena were evaluated at one month and one year postop. Data were analyzed to determine difference between groups for astigmatism, mean spherical equivalent (MRSE), uncorrected (UDVA) and corrected (CDVA) monocular distance visual acuity, complication rate (acute and chronic), and ECC...
2017: Seminars in Ophthalmology
R Autrata, I Krejčířová, L Griščíková, Z Doležel
UNLABELLED: Our study evaluated the visual and refractive results of LASEK and anterior chamber phakic intraocular lens (pIOL) implantation performed for high myopic anisometropia with amblyopia and contact lens intolerance in children compared with conventional treatment by contact lenses.Fourty-three patients (Group A) aged 3 to 7 years (mean, 5,6 years) with high myopic anisometropia and amblyopia had performed multizonal LASEK (27 eyes) or pIOL Verisyse implantation (16 eyes) on the more myopic eye in general anesthesia...
2016: Ceská a Slovenská Oftalmologie
Melisa Ahmedbegović Pjano, Amila Alikadić-Husović, Senad Grišević, Adis Pašalić, Ajla Pidro, Mirko Ratković, Maja Bohač, Nikica Gabrić, Refet Gojak
AIM: To evaluate efficacy and safety of iris-supported phakic lenses (Verisyse) for treating moderately high myopia. METHODS: This prospective clinical study included 40 eyes from 29 patients, who underwent implantation of Verisyse for correction of myopia from -6.00 to -14.50 diopters (D) in the Eye Clinic ''Svjetlost'', Sarajevo, from January 2011 to January 2014. Uncorrected distance visual acuity (UDVA), manifest residual spherical equivalent(MRSE), postoperative astigmatism, intraocular pressure(IOP), endothelial cell (EC) density were evaluated at one, three, six and twelve months...
February 1, 2016: Medicinski Glasnik
I Schmidt, A Langenbucher, S Moussa, F Schirra, B Seitz, T Eppig
BACKGROUND: Evaluation of refractive predictability with retroiridal implantation of a Verisyse(TM) iris-claw lens (AMO) and optimization of the IOL-constants recommended by the manufacturer. PATIENTS AND METHODS: A retrospective study after retroiridal iris-claw lens implantation in the years 2007-2012 including 52 eyes of 50 patients with a lack of capsular support was carried out. Follow-up data was recorded on average 5 weeks after surgery. Demographic data, indications, accompanying diseases, biometrical data and refractive outcome were analysed and an individualization of the intraocular lens constants for the SRK/T-, Holladay-1, Hoffer-Q and Haigis-formula was carried out...
March 2015: Der Ophthalmologe: Zeitschrift der Deutschen Ophthalmologischen Gesellschaft
J Gonnermann, S Amiri, M Klamann, A-K B Maier, A M Joussen, P W Rieck, N Torun, E Bertelmann
BACKGROUND: The aim of this study was to evaluate the indication, visual and refractive outcome, endothelial cell loss and complication rate after implantation of a posterior iris-claw aphakic intraocular lens (IOL). PATIENTS AND METHODS: This retrospective study comprised 62 eyes of 56 patients without adequate capsular support undergoing posterior iris-claw aphakic IOL implantation (Verisyse™/Artisan®) between 2006 and 2012. Mean follow-up was 34 months (range from 13 to 78 months)...
August 2014: Klinische Monatsblätter Für Augenheilkunde
Alexander K Schuster, Natalie Kaplan, Norbert Pfeiffer, H Burkhard Dick, Urs Vossmerbaeumer
BACKGROUND: Phakic anterior chamber iris-fixated IOL (PIOL) are established for the correction of high myopia. These patients require attention to macular pathologies. This study was to evaluate the quality of imaging through the PIOLs. METHODS: 54 eyes of 31 myopic and hyperopic patients with Verisyse, Verisyse toric, and Veriflex phakic iris-fixated IOL were included. Mean preoperative refraction was -11.0 D and +5.7 D, respectively; mean follow-up time was 7...
2015: Seminars in Ophthalmology
Majid Moshirfar, Lauren M Imbornoni, Erik M Ostler, Valliammai Muthappan
PURPOSE: To evaluate the incidence rate and indications for explantation of Verisyse phakic intraocular lenses (pIOLs) over a 13.6 year period. SUBJECTS AND METHODS: Case series describing six cases of explantation of Verisyse pIOLs, out of 213 eyes with Verisyse pIOLs, implanted over a 13.6 year period by one surgeon at one institution, with mean follow-up of 5.6 years per eye. RESULTS: Four pIOLs were removed to facilitate extraction of a visually significant cataract, one was removed due to both cataract formation and development of corneal decompensation, and another was removed due to development of localized peripheral corneal decompensation...
2014: Clinical Ophthalmology
T Kohnen, F H Hengerer
The intraocular correction of aphakia in the anterior chamber currently consists of two options: an angle supported intraocular lens (IOL, Kelman Multiflex) and an iris fixated IOL (Artisan/Verisyse). The angle supported IOL is fixated with four haptic points in the anterior chamber and the iris fixated IOL is enclavated to the anterior iris surface. Acceptable results of both IOLs are reported in the literature; however both IOLs show some long-term complications in some eyes. Alternatives to these anterior chamber IOLs to correct aphakia are the retropupillary fixated Artisan and sclera fixated IOLs...
April 2014: Der Ophthalmologe: Zeitschrift der Deutschen Ophthalmologischen Gesellschaft
W Sekundo, T Bertelmann, S Schulze
BACKGROUND: Overview of the retropupillary implantation of iris claw intraocular lenses (Artisan®,Ophtec, Groningen, Niederlande and Verisyse(TM),AMO, Santa Ana CA). MATERIAL AND METHODS: A literature search and review of implantation techniques, patient selection, potential complications and management strategies. RESULTS: This approach has the advantage of a simple implantation technique, an anatomically correct implantation site (as compared to endocapsular implantation) and a relatively low complication rate...
April 2014: Der Ophthalmologe: Zeitschrift der Deutschen Ophthalmologischen Gesellschaft
Johannes Gonnermann, Necip Torun, Matthias K J Klamann, Anna-Karina B Maier, Christoph V Sonnleithner, Antonia M Joussen, Peter W Rieck, Eckart Bertelmann
BACKGROUND: To evaluate the indication, visual outcome, and complication rate after implantation of a posterior iris-claw aphakic intraocular lens (IOL) during penetrating keratoplasty. METHODS: This retrospective study comprised 23 eyes (23 patients) without adequate capsule support undergoing posterior iris-claw aphakic IOL implantation (Verisyse/Artisan) during penetrating keratoplasty between 2005 and 2010. Mean follow-up was 18 months (range from 12 to 37 months)...
April 2013: Graefe's Archive for Clinical and Experimental Ophthalmology
Maher Saleh, Antoine Heitz, Tristan Bourcier, Claude Speeg, Bernard Delbosc, Michel Montard, David Gaucher
PURPOSE: To report the results and safety of sutureless intrascleral haptic fixation in traumatized eyes and to compare this procedure with retropupillary iris-claw intraocular lens (IOL) fixation. SETTING: University Hospital of Strasbourg, Strasbourg, France. DESIGN: Interventional case series. METHODS: Patients with traumatic cataract and severely damaged capsular bags were divided into 2 groups (Group 1: intrascleral IOLs [Acrysof MN60 AC]; Group 2: retropupillary iris-claw IOLs [Verisyse])...
January 2013: Journal of Cataract and Refractive Surgery
Zhe Dong, Ning-li Wang, Lei Hao, Huai-zhou Wang, Hui Zhang
OBJECTIVE: To analyze the long-term safety of implantation of iris-fixed phakic intraocular lens (IOL) Verisyse for the treatment of high myopia. METHODS: One hundred and eighteen eyes of 59 cases implanted Verisyse for high myopia in Eye Center of Tongren Hospital from Jan. 2005 to Jan. 2007 were followed up for 48 to 72 months, mean time period was (56.2 ± 16.9) months. There were 32 male cases (64 eyes) and 27 female cases (54 eyes). Age ranged from 22 to 39 years old, mean (26...
August 2012: [Zhonghua Yan Ke za Zhi] Chinese Journal of Ophthalmology
Johannes Gonnermann, Matthias K J Klamann, Anna-Karina Maier, Julia Rjasanow, Antonia M Joussen, Eckart Bertelmann, Peter W Rieck, Necip Torun
PURPOSE: To evaluate the indications, visual outcomes, and complication rate after implantation of a posterior chamber iris-claw aphakic intraocular lens (IOL). SETTING: Department of Ophthalmology, University Medicine Charité Berlin, Berlin, Germany. DESIGN: Retrospective case series. METHODS: Eyes without adequate capsule support had posterior chamber iris-claw aphakic IOL implantation (Verisyse/Artisan) between 2005 and 2010...
December 2012: Journal of Cataract and Refractive Surgery
Mohamadreza Sedaghat, Mehran Zarei-Ghanavati, Mohammad-Reza Ansari-Astaneh, Virag Patel, Shameema Sikder
PURPOSE: To evaluate the clinical features, and visual outcomes of sterile uveitis after iris-fixated phakic intraocular lens implantation (pIOLs) (Artisan-Artiflex(®) and Verisyse-Veriflex(®)). MATERIAL AND METHODS: In this retrospective non-comparative case series, the medical records of 117 eyes implanted with Artisan-Artiflex(®) (Ophtec BV, Groningen, Netherlands) and Verisyse-Veriflex(®) (AMO, Santa Ana, CA) iris claw phakic IOLs were analyzed for postimplantation sterile uveitis...
April 2012: Middle East African Journal of Ophthalmology
Brent S Betts, Thomas J Oberg, Maylon Hsu, Majid Moshirfar
Both choroidal neovascularization during pregnancy, and choroidal neovascularization following implantation of phakic intraocular lenses have been reported in the literature. To our knowledge, this is the first case reported of a gravid woman developing choroidal neovascularization in an eye with a phakic intraocular lens. A 31-year-old woman became aware of her pregnancy three weeks after placement of the Verisyse™ iris-supported phakic intraocular lens. She was at 15 weeks gestation when she developed a Fuch's spot consistent with choroidal neovascularization...
2012: Open Ophthalmology Journal
K Schöpfer, A Berger, C Korb, B M Stoffelns, N Pfeiffer, W Sekundo
PURPOSE: After implantation of retropupillary fixated iris-claw lenses, changes of the objective refraction can occur depending on the patients' position. The purpose of this study was to evaluate and quantify these changes as well as the influencing factors. METHODS: Within a retrospective study, postoperative refraction visual, acuity and anterior chamber depth after implantation of a retropupillary fixated iris-claw lens (Artisan® / Verisyse®) were measured in 51 eyes (49 patients) depending on their head position...
December 2012: Graefe's Archive for Clinical and Experimental Ophthalmology
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"